- Supported exchanges /
- F /
- 3350.F
AADI BIOSCIENCES DL-0001 (3350 F) stock market data APIs
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
AADI BIOSCIENCES DL-0001 Financial Data Overview
| 1.82 | |
| 1.83 | |
| - | |
| 1.83 | |
| 1.81 | |
| 1.18-4.82 | |
| 44 799 K | |
| 24 615 K | |
| 23 817 K | |
| -1.35 | |
| 0.372 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
AADI BIOSCIENCES DL-0001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 23 817 K
- EBITDA -70 472 000
- Earnings Per Share -2.25
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get AADI BIOSCIENCES DL-0001 Earnings via APIs
- Latest Release 2021-06-30
- EPS/Forecast -6
Get AADI BIOSCIENCES DL-0001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
